Based on the fold change as well as the result of PRM, candidate exosomal proteins RPL14, and RPL13 were selected for validation by WB analysis in individual samples ( 18 IM-R and 18 IM-S CML patients). The gene discussed is RPL13; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.